학술논문
An Open–Label, Randomized, Multi–Center Study Comparing the Sequence of High Dose Aldesleukin (Interleukin–2) and Ipilimumab (Yervoy) in Patients with Metastatic Melanoma
Document Type
Article
Author
Source
In: OncoImmunology . (OncoImmunology, 2021, 10(1))
Subject
Language
English
ISSN
2162402X
21624011
21624011